Analysts Set Axon Enterprise, Inc. (NASDAQ:AXON) PT at $504.92

Axon Enterprise, Inc. (NASDAQ:AXON) has earned an average rating of “Buy” from the fourteen ratings firms that are currently covering the company, MarketBeat reports. Fourteen research analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued ratings on the stock in the last year is $524.85.

Several research firms recently weighed in on AXON. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC upped their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Northland Securities upped their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities upped their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research report on Thursday, October 31st. Finally, Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $639.97 on Friday. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $48.80 billion, a P/E ratio of 165.37, a PEG ratio of 6.09 and a beta of 1.04. The stock’s 50 day moving average is $618.90 and its 200 day moving average is $477.78. Axon Enterprise has a twelve month low of $247.04 and a twelve month high of $698.67.

Insider Buying and Selling

In other news, Director Julie A. Cullivan sold 1,261 shares of the firm’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the transaction, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,545 shares of company stock valued at $30,721,337. 6.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Avestar Capital LLC bought a new position in shares of Axon Enterprise in the 4th quarter valued at about $220,000. Gladstone Institutional Advisory LLC lifted its stake in Axon Enterprise by 3.5% in the fourth quarter. Gladstone Institutional Advisory LLC now owns 1,699 shares of the biotechnology company’s stock worth $1,010,000 after purchasing an additional 58 shares during the last quarter. Louisiana State Employees Retirement System lifted its stake in Axon Enterprise by 137.5% in the fourth quarter. Louisiana State Employees Retirement System now owns 9,500 shares of the biotechnology company’s stock worth $5,646,000 after purchasing an additional 5,500 shares during the last quarter. JSF Financial LLC raised its stake in shares of Axon Enterprise by 1.4% during the fourth quarter. JSF Financial LLC now owns 2,899 shares of the biotechnology company’s stock valued at $1,723,000 after acquiring an additional 41 shares in the last quarter. Finally, Stonebridge Financial Group LLC bought a new stake in shares of Axon Enterprise during the fourth quarter valued at approximately $53,000. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.